About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 13 record(s)
Req # A 2022_0021
January 1, 2022 to present, internal and consultant reports, governance structure plans, costs incurred to setting up and projected costs and budget projections for Canada Growth Fund. Include a breakdown of launching costs, of logo and branding costs/projections.Organization: Canada Development Investment Corporation
November 2023
Nothing to report this month
Organization: Nanaimo Port Authority
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Nothing to report this month
Organization: Canada Development Investment Corporation
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A 2021_0008
Information on potential fundings available for profits organization working in the Sustainability and Climate Change sector. This includes funding available for research projects, technology and application development, sustainability services companies, supply chain sustainability and similar. Record / list of funding available, presentation or briefing notes will be much appreciated. We are a company dedicated to develop sustainability and ESG solutions based in headquartered in Canada and we plan to use the funds for research and development, hiring staff and for sales and marketing activities.Organization: Canada Development Investment Corporation
November 2021
Req # A-2020-03994
Copies of all analysis, correspondence, discussions, briefings and memos about the economic impact and consequences of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all levels. Include Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-10638
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and BC Ministry of Health, Pharmaceutical Services Division over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-19383
The daily calendar of meetings, calls and other taskings for Douglas Clark from May 1, 2021 to October 14, 2021.Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-10631
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Amgen Canada Inc over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
November 2021